Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Inspyr Therapeutics, Inc. | Financial_Report.xls |
| 10-K - ANNUAL REPORT - Inspyr Therapeutics, Inc. | v303803_10k.htm |
| EX-31.2 - EXHIBIT 31.2 - Inspyr Therapeutics, Inc. | v303803_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Inspyr Therapeutics, Inc. | v303803_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Inspyr Therapeutics, Inc. | v303803_ex31-1.htm |
| EX-4.26 - EXHIBIT 4.26 - Inspyr Therapeutics, Inc. | v303803_ex4-26.htm |
| EX-32.2 - EXHIBIT 32.2 - Inspyr Therapeutics, Inc. | v303803_ex32-2.htm |
| EX-4.27 - EXHIBIT 4.27 - Inspyr Therapeutics, Inc. | v303803_ex4-27.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (SEC File No. 333-171783) of Genspera, Inc. of our report dated March 6, 2012 relating to our audits of the financial statements which appear in this Annual Report on Form 10-K of Genspera, Inc. for the years ended December 31, 2011 and 2010.
| /s/ RBSM LLP | |
| New York, New York | |
| March 6, 2012 |